Piper Sandler Downgrades Fate Therapeutics (FATE) to Neutral
Tweet Send to a Friend
(Updated - January 6, 2023 6:13 AM EST)
Piper Sandler analyst Edward Tenthoff downgraded Fate Therapeutics (NASDAQ: FATE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Edward Tenthoff downgraded Fate Therapeutics (NASDAQ: FATE) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
